Searched for
ROCHE PHARMA COMPANY
Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...15 May, 2026, 07.43 AM IST- Alembic Pharma gets USFDA tentative nod for generic prostate cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate c...14 May, 2026, 04.32 PM IST
- Roche Pharma launches India’s first 7-minute injectable immunotherapy for lung cancerRoche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven min...14 May, 2026, 02.09 PM IST
- Indian companies announce $1.1 billion investment in US, to create 1,500 jobsTwelve Indian companies announced over USD 1.1 billion in US investments across aerospace, defense, energy, and AI sectors at the SelectUSA...06 May, 2026, 07.19 AM IST
- Roche moves SC against Natco’s launch of generic Risdiplam in IndiaF. Hoffmann-La Roche AG has approached the Supreme Court. This follows a Delhi High Court decision permitting Natco Pharma to introduce a g...14 Oct, 2025, 06.54 PM IST
- Delhi HC allows Natco Pharma to launch risdiplam, rejects Roche pleaThe Delhi High Court has permitted Natco Pharma to launch its affordable generic version of risdiplam, a crucial drug for spinal muscular a...09 Oct, 2025, 08.53 PM IST
- Roche made over 100 times the cost of a medicine that it sold in India, calculations show; company defends itselfA recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal muscular atrophy (SM...28 Apr, 2025, 11.50 AM IST
- Delhi HC asks Natco Pharma to pause Risdiplam launch amid patent disputeThe Delhi High Court has ordered Natco Pharma to maintain status quo on the launch of Risdiplam until April 2. Roche, which holds the paten...26 Mar, 2025, 06.51 PM IST
- Delhi HC rejects Roche's plea to block Natco Pharma on Risdiplam patentThe Delhi High Court denied Roche's request to temporarily restrain Natco Pharma from producing its spinal muscular atrophy drug, citing pu...24 Mar, 2025, 09.58 PM IST
- Roche launches spinal muscular atrophy treatment drug in India priced at around Rs 6 lakh per bottleSince its launch, over 4,000 SMA patients across over 50 countries have benefitted from the drug, Roche said in a statement.29 Jul, 2021, 05.46 PM IST
- Roche India gets emergency use approval for antibody cocktail used in COVID-19 treatmentRoche said that the production process for this drug is “very complex” and the company will do everything to ensure an equitable distributi...06 May, 2021, 07.45 AM IST
- Roche Pharma India expands partnership with Cipla for key oncology medicinesRoche Pharma India has signed a "distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distrib...18 Jun, 2020, 11.45 AM IST
- Roche and Cipla tie up to market anti cancer drugsRoche said this partnership will also enable it to focus on bringing new, transformative medicines to patients in India.28 Feb, 2018, 08.54 AM IST
- Roche launches new breast cancer drugs in IndiaRoche Products (India) Private Ltd is a wholly owned subsidiary of the Switzerland based Roche Group and has products in therapeutic areas .12 Oct, 2015, 04.30 PM IST
- Cipla’s patent win against Roche boosts hopes of generic drugmakersThe Delhi HC ruling favouring India’s second largest drugmaker Cipla has come as a shot in the arm for other generic makers who are fightin...10 Sep, 2012, 11.15 AM IST
- Pharma giant Roche starts cost-cutting programmeSwiss pharmaceutical giant Roche said on Friday it was launching a cost-cutting programme which could lead to job cuts03 Sep, 2010, 12.49 PM IST
- Roche signs marketing pact with Elder PharmaRoche announced on Thursday that it had signed a marketing agreement with domestic company Elder Pharma for its osteoporosis drug, Bonviva.16 Dec, 2006, 02.19 AM IST
Load More
